Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site


Click on country-registry for comparison

FlagCountry-registryRegistration periodNumber of case% of cases by extent of disease5-year absolute survival %
LocalizedRegionalDis. Met.UnknownLocalizedRegionalDis. Met.Unknown
Cuba1994-199580051.323.01.324.565.534.510.022.2
India - Chennai1990-19997226.685.53.64.344.330.30.034.1
India - Karunagappally1991-19974630.445.713.010.955.619.00.00.0
India - Mumbai1992-1994188033.251.19.76.157.116.50.523.2
Singapore1993-199731135.712.22.349.863.628.614.341.8
Thailand - Chiang Mai1993-199715311.882.43.82.052.421.416.70.0
Thailand - Lampang1990-200016217.361.77.413.653.431.625.045.5
Thailand - Songkhla1990-199913821.039.98.730.459.531.942.421.9
Turkey - Izmir1995-199747832.123.07.537.474.845.147.665.8



Graphs:


Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period